Join key decision-makers, scientific leaders, patient groups, industry partners and others for a full day event to discuss the new era in cancer care. On 28 January 2020 let’s find the answers to some of today’s most pressing questions:

What are the latest developments in cancer treatment and can we expect a cancer cure in the near future?

All Europeans deserve better and faster access to innovative treatments but how can we achieve this?

In what way are European countries responding to the challenges posed by lung cancer?

MODERATOR: Vivek Muthu, Adviser at The Economist Intelligence Healthcare Unit

KEYNOTE SPEECHES

9:00

Deepak Khanna, Senior Vice President and Regional President for Europe, Middle East, Africa and Canada, MSD Oncology

Maggie De Block, Minister of Social Affairs and Public Health, Belgium

Martin Seychell, Deputy Director-General for Health and Food Safety, DG SANTE European Commission

THE FUTURE OF TREATING AND LIVING WITH CANCER

10:30

What are the developments in the area of Research & Development, how will they change the treatment of cancer in the future, and what does this mean for survivorship?

PRESENTATION: Advances in the Treatment of Cancer: yesterday, today, tomorrow

Ahmad Awada, Head of the Oncology Medicine Department at Jules Bordet Cancer Institute Brussels, Belgium

PANEL

Simon Ekman, MD, Associate Professor, Oncologist, Karolinska Institute

Antonella Cardone, Director, European Cancer Patient Coalition, Board member of Pancreatic Cancer Europe

Michael Holmes, Associate Vice President, Global Medical Affairs Oncology, MSD

Nikos Dedes, Chair, Positive Voice, Greece

Lunch break from 12:00 - 13:00

THE FUTURE OF ACCESS TO INNOVATION

13:00

What are the solutions to provide cancer patients with timely access to new, innovative oncology treatments within financially sustainable healthcare systems?

PRESENTATION: Cancer in Europe: Disease burden, costs and access to medicines

Bengt Jönsson, Professor, The Swedish Institute for Health Economics

PANEL

Lieve Wierinck, Board member of Digestive Cancers Europe

Ortwin Schulte, Head of Unit Health Policy, German Permanent Representation to the EU

Wim Groot, Professor of Health Economics, Maastricht University,

Deepak Khanna, Senior Vice President and Regional President for Europe, Middle East, Africa and Canada, MSD Oncology

Coffee break 14:30 - 15:00

THE FUTURE OF LUNG CANCER

15:00

The Economist Intelligence Unit has conducted a comparative analysis of lung cancer policies in 27 European countries. What actions need to be taken to address the burden of lung cancer in Europe?

PRESENTATION: Breathing in a New Era: recommendations to improve lung cancer policies in 27 European countries

Mary Bussell, PhD, Associate, Health Policy and Clinical Evidence, The Economist Intelligence Unit

PANEL

Marina Garassino, MD, Medical Consultant, Medical Oncology Division in the National Tumor Institute of Milan, Italy

Merel Hennink, Patient Advocate and Ambassador of Lung Cancer Europe

CLOSING KEYNOTE

Networking reception from 17:00.